ClinicalTrials.Veeva

Menu

REFLECT Scoliosis System Post Approval Study

Globus Medical logo

Globus Medical

Status

Enrolling

Conditions

Idiopathic Scoliosis

Treatments

Device: REFLECT Scoliosis Correction System

Study type

Interventional

Funder types

Industry

Identifiers

NCT06298812
Protocol Rev 0 11July2023

Details and patient eligibility

About

The purpose of this multi-center, prospective, single-arm registry Post-Approval Study (PAS) is to evaluate the radiographic and clinical outcomes of 100 patients with idiopathic scoliosis treated with the REFLECT™ Scoliosis Correction System, as a condition of HDE approval

Full description

The REFLECT™ Scoliosis Correction System is designed for continued growth and mobility of the spine as well as straightening of the spine by holding the segments in a more natural anatomic position using non-rigid materials. REFLECT™ uses a growth modulation technique in which growth of the patient is used to achieve progressive scoliosis correction.

The REFLECT™ Scoliosis Correction System is indicated for skeletally immature patients who require surgical treatment to obtain and maintain correction of progressive idiopathic scoliosis, who have a major Cobb angle of 30 to 65 degrees whose osseous structure is dimensionally adequate to accommodate screw fixation, as determined by radiographic imaging. Patients should have failed bracing and/or are intolerant to brace wear.

A total of 100 patients will be prospectively enrolled and treated at a minimum of 5 U.S. sites, with a maximum of 20 subjects at any one site, with sequential enrollment from each site. Patients will be followed for 5 years with evaluations at the following timepoints: preoperative, intraoperative, immediate postoperative (first erect), 6 weeks, 6 months, 12 months, 24 months, and 60 months. Primary and secondary outcomes from 100 patients enrolled and treated with REFLECT™ will be summarized.

Enrollment

100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of progressive idiopathic scoliosis
  • Preoperative major Cobb angle 30°-65°
  • Preoperative flexibility to ≤30° on side bending radiograph (left or right)
  • Skeletally immature at the time of surgery with Risser sign <5 or Sanders score <8
  • Osseous structure dimensionally adequate to accommodate screw fixation, as determined by radiographic imaging
  • Failed or intolerant to bracing
  • Signed informed consent and/or assent forms specific to this study

Exclusion criteria

  • Prior spinal surgery at the level(s) to be treated
  • Documented poor bone quality, defined as a T-score of -1.5 or less
  • Presence of any systemic infection, local infection, or skin compromise at the surgical site
  • Any medical or surgical condition which would preclude the potential benefit of spinal surgery, such as coagulation disorders, allergies to the implant materials, and patient's unwillingness or inability to cooperate with post-operative care instructions
  • Unwillingness, inability, or living situation (e.g. custody arrangements, homelessness, detention) that would preclude ability to return to the study site for follow-up visits as described in protocol and Informed Consent
  • Active participation in a drug or device study that is more than minimal risk such that participation would confound the measurements of the present study

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

REFLECT
Other group
Description:
Enrolled patients are treated with the REFLECT Scoliosis System. This is an HDE-approved device.
Treatment:
Device: REFLECT Scoliosis Correction System

Trial contacts and locations

1

Loading...

Central trial contact

Shannon Bahn; Rebecca Smith

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems